Hasta la próxima

Auto reproducción

Improved outcomes for Kaposi sarcoma using pegylated liposomal doxorubicin | Matthew Coldiron

1 vistas • 06/15/23
Compartir
Empotrar
administrator
administrator
Suscriptores
0

A study conducted in Mozambique shows pegylated liposomal doxorubicin (PLD) was safe, well-tolerated and effective as first-line treatment for Kaposi’s sarcoma, a common HIV-associated malignancy.

Mostrar más
0 Comentarios sort Ordenar por
Comentarios de Facebook

Hasta la próxima

Auto reproducción